Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NGM BIOPHARMACEUTICALS, INC.

(NGM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 1 2212 0901 487--
Entreprise Value (EV)1 9761 9431 3581 3951 427
P/E ratio -21,8x-20,2x-11,9x-8,50x-7,13x
Yield -----
Capitalization / Revenue 11,8x23,9x17,8x35,6x60,6x
EV / Revenue 9,42x22,2x16,3x33,4x58,1x
EV / EBITDA -23,4x-20,0x-14,9x-8,62x-7,41x
Price to Book -----
Nbr of stocks (in thousands) 66 04768 99777 338--
Reference price (USD) 18,530,319,219,219,2
Announcement Date 03/17/202003/04/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 10910487,483,441,824,6
EBITDA1 2,91-41,7-97,3-91,4-162-193
Operating profit (EBIT)1 --49,3-104-122-179-222
Operating Margin --47,7%-119%-146%-428%-905%
Pre-Tax Profit (EBT)1 --42,8-102-125-180-226
Net income1 --42,8-102-125-180-226
Net margin --41,3%-117%-150%-431%-919%
EPS2 -0,01-0,85-1,50-1,62-2,26-2,70
Dividend per Share ------
Announcement Date 03/25/201903/17/202003/04/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 19,821,616,822,722,518,4
EBITDA ------
Operating profit (EBIT)1 -27,7-27,8-36,6-27,8-29,4-38,6
Operating Margin -140%-129%-218%-123%-131%-210%
Pre-Tax Profit (EBT)1 -28,0-27,5-36,7-29,5-31,4-36,5
Net income1 -28,0-27,5-36,7-29,5-31,4-36,5
Net margin -142%-128%-219%-130%-139%-198%
EPS2 -0,40-0,36-0,48-0,38-0,40-0,46
Dividend per Share ------
Announcement Date 03/04/202105/06/202108/05/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 -24614712992,260,5
Leverage (Debt / EBITDA) -5,88x1,51x1,41x0,57x0,31x
Free Cash Flow1 --44,7-85,4-54,0-115-146
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 -3,491,883,802,051,98
Capex / Sales -3,37%2,15%4,55%4,91%8,05%
Announcement Date 03/25/201903/17/202003/04/2021---
1 USD in Million
Key data
Capitalization (USD) 1 487 212 509
Net sales (USD) 87 368 000
Number of employees 210
Sales / Employee (USD) 416 038
Free-Float 70,5%
Free-Float capitalization (USD) 1 048 073 421
Avg. Exchange 20 sessions (USD) 7 490 835
Average Daily Capital Traded 0,50%
EPS & Dividend